Clinical trial
Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
NCT02400359 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- October 31, 2014
- Completion date
- June 30, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.